Controlled ingestion of peanut protein could help build tolerance in peanut allergy sufferers. Authors of a new study published in the New England Journal of Medicine say an oral immunotherapy drug they tested could be the first FDA-approved medication of its kind for people with peanut allergy. The medication, called AR101, is derived from peanut protein.
The 'gateway pattern' of adolescent substance use is changing, and marijuana is increasingly the first substance in the sequence of adolescent drug use. Traditionally, students experiment with cigarettes and alcohol before cannabis, but since 2006, less than 50 percent of adolescents try cigarettes and alcohol before they try cannabis for the first time.
Firearm injuries and deaths among children are a public health issue. This study used telephone survey data from 5,200 people in Washington to describe how common firearms were in households with children in the state and to assess the association between children living in a home with a firearm stored unsafely and an adult who reported misusing alcohol.
In a study of estimated exposure to air pollution at mothers' homes during pregnancy, 1 of 3 airborne pollutants was associated with increased risk of autism spectrum disorder (ASD) in children in a Canadian metropolitan area with relatively low ambient air pollution levels. What causes ASD isn't known but some previous research has suggested environmental contaminants and air pollution may be potential risk factors. This study included nearly all births in Vancouver, British Columbia, from 2004 through 2009.
Nearly a third of parents say they are not planning to get their child the vaccine this year, according to the C.S. Mott Children's Hospital National Poll on Children's Health at the University of Michigan.
Researchers from Ann & Robert H. Lurie Children's Hospital of Chicago and colleagues estimate that nearly 8 percent of US children (about 5.6 million) have food allergies, with nearly 40 percent allergic to more than one food.
The final research results for a new treatment for protection against accidental exposure to peanut was presented today at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting and published in the New England Journal of Medicine.
Facioscapulohumeral muscular dystrophy (FSHD) is the most prevalent dominantly inherited muscular dystrophy in the world. To date, there are no pharmacologic treatments available for the more than 850,000 people affected worldwide. Developing models to use for testing potential therapeutics has been a challenge for the research community.
A newborn baby's brain responds to being touched on the face, according to new research co-led by UCL. Babies use this sense of touch -- facial somatosensation -- to find and latch onto their mother's nipple, and should have this ability from birth. Premature babies often have difficulty feeding, and underdevelopment of their facial sensitivity may be one of the main causes.
For children and adults with food allergies, personal self-injectable epinephrine devices are crucial to treating severe reactions such as anaphylaxis if there is unintended exposure to allergens. Autoinjectors have become very expensive, although the drug they inject is cheap. In this study of simulated children with peanut allergy, researchers estimated value-based pricing for the devices, which is a method of drug pricing where drug costs are based on the magnitude of the benefit they provide.